Abstract (+) (S)‐ and (−) (R)‐ trans ‐1,2‐cyclopropanedicarboxylic acids (C3A), (+) (S)‐ and (−) (R)‐ trans ‐1,2‐diaminocyclopropanes (C3B), (+) (S)‐ and (−) (R)‐ trans ‐2‐phenylcyclopropylamines (øC3B), (+) (S)‐ and (−) (R)‐ trans ‐1,2‐bis(methylamino)‐cyclopropanes (C3MB), and (+) (S)‐ and (−) (R)‐ trans ‐(2‐phenylcyclopropyl)‐methylamines (øC3MB) were prepared.
No takes yet. Share an insight, caveat, or question.
Overberger et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: